Certain Sglt2 Inhibitors Glp1 Ras For T2dm Also Cut Cv Risk | Latest News RSS feed

Certain Sglt2 Inhibitors Glp1 Ras For T2dm Also Cut Cv Risk - Latest News


Certain SGLT2 inhibitors, GLP-1 RAs for T2DM also cut CV risk

(HealthDay)—Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) demonstrate significant cardiovascular (CV) benefit and should be used f... read more

Hepatic encephalopathy

Prostate Cancer Risk Lower in Long-Term Users of Lipid-Lowering Drugs Feature articles Magnetic Resonance Imaging Prior to Initial Prostate Biopsy Advances in Imaging, Therapies Bode Well for nmCRPC M... read more

Women with CVD have worse self-reported outcomes

(HealthDay)—Compared with men, women with atherosclerotic cardiovascular disease (ASCVD) are more likely to report poorer patient experience, lower health-related quality of life, and poorer perceptio... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us